NAVSYRNA
Live / Applied — Non-final action mailed (as of 24 Oct 2025)
What this means for you
Not registered yet, but its 28 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99363013
- Mark type
- Stylized text
- Filed
- 28 Aug 2025
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating cancer and oncological disorders; Pharmaceutical preparations for treating inflammatory disorders, such as lupus erythematosus, rheumatoid arthritis, multiple sclerosis, asthma, respiratory system disorders, plaque psoriasis, alopecia, atopic dermatitis, autoimmune diseases; Pharmaceutical preparations for treating metabolic or skeletal disorders, such as obesity, diabetes, weight reduction and long-term weight loss maintenance, osteoporosis, increasing bone density, bone formation and growth; Pharmaceutical preparations for treating or preventing cardiovascular and cerebrovascular disorders, such as atherosclerosis, coronary artery disease, peripheral artery disease, carotid artery disease, aortic stenosis, hyperlipidemia, hyperlipoproteinemia(a), hypercholesterolemia, myocardial infarction, stroke, heart failure, stable or unstable angina, atrial fibrillation, and reduction of risk of major cardiovascular events; Pharmaceutical preparations
Owner
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 24 Oct 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 24 Oct 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 24 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Oct 2025 — NON-FINAL ACTION E-MAILED
- 24 Oct 2025 — NON-FINAL ACTION WRITTEN
- 23 Oct 2025 — ASSIGNED TO EXAMINER
- 28 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 28 Aug 2025 — NEW APPLICATION ENTERED